| Price | 17.99 |
| Price Change Today | -$0.58 (-3.12%) |
| P&P rating | ![]() |
| Zacks Rank | 3 - HOLD |
| Open Price | $18.69 |
| Previous Close | $18.57 |
| Daily Range | $17.82 - $18.99 |
| 52-Week Range | $4.75 - $20.45 |
| Volume | 654,186 |
| Pharmacyclics Inc. is a pharmaceutical company developing products to improve upon therapeutic approaches to cancer, atherosclerosis and retinal disease. The company's products are ring-shaped small molecules called texaphyrins. These patented agents are derived from Pharmacyclics' versatile technology platform for designing and synthesizing energy-potentiating drugs. The texaphyrins localize in cancer cells, atherosclerotic plaque and neovasculature, where they can be activated by forms of energy, including X-rays and light to reduce diseased tissue. | |




Comments: 0 | Comment
Comments: 12 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment
Comments: 0 | Comment